Shelterin complex and associated factors at human telomeres
about
Insertion of Retrotransposons at Chromosome Ends: Adaptive Response to Chromosome MaintenanceTelomeres-structure, function, and regulationTelomerase Regulation from Beginning to the EndTelomere structure and maintenance gene variants and risk of five cancer typesSuper-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formationMolecular Architecture of Full-length TRF1 Favors Its Interaction with DNASports and Exercise at Different Ages and Leukocyte Telomere Length in Later Life--Data from the Berlin Aging Study II (BASE-II)Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemiaTRIP6 and LPP, but not Zyxin, are present at a subset of telomeres in human cells.Zscan4 interacts directly with human Rap1 in cancer cells regardless of telomerase statusGene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.Caenorhabditis elegans POT-1 and POT-2 repress telomere maintenance pathways.POT1-TPP1 Binding and Unfolding of Telomere DNA Discriminates against Structural Polymorphism.Telomere status in chronic lymphocytic leukemia with TP53 disruption.Stem cell aging in adult progeria.ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisExosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways.Chromatin structure in telomere dynamicsBRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivoNon-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damageBRCA1 in the DNA damage response and at telomeresMutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects.Nuclear alpha spectrin: Critical roles in DNA interstrand cross-link repair and genomic stability.Heat shock-induced dissociation of TRF2 from telomeres does not initiate a telomere-dependent DNA damage response.SNM1B/Apollo in the DNA damage response and telomere maintenanceTelomere length regulation through epidermal growth factor receptor signaling in cancer.Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis.Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span.DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system.Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I.Crystal structure of a tankyrase 1-telomere repeat factor 1 complex.Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.Relative telomere length and oxidative DNA damage in hypertrophic ligamentum flavum of lumbar spinal stenosis
P2860
Q26771437-4EE688AA-712C-442D-AC37-A2D513122AF7Q26853108-70A18A4F-0BAD-4BC9-9B7E-7C861C9D8EA4Q28075938-C407A5C7-040F-41B2-A665-73964AAB30E0Q28397509-05945F60-5A45-415E-81F7-278A37266ACCQ28854371-321B7B83-B2DC-441B-92F3-9E5EBCF4AE7FQ30392263-2121EAF9-4FEE-47B1-9BDE-4D235BD3B9F2Q31029927-BA0349CD-3293-4944-9E59-31125E09A9E8Q33660516-346FA229-DE2C-4A4E-A87C-F5EC7471B290Q33881810-5A07ABC0-4AE7-4A0C-8D4B-5B683BD4CD4AQ34420523-9157061A-1033-4DB8-A992-05746BA8B506Q34514751-59F309CB-2AD6-40BD-B552-CD7733779E5AQ34518947-E3818706-950E-4E8E-AC35-FC95D660DD6EQ34580208-2F011962-8F82-4825-9209-8DE86685D285Q36016284-A53C98B6-5394-41EE-AC01-8D1813AE2FBFQ36093789-67A8CCC1-7A2F-4B26-A8A8-53E64049E38DQ36118417-CBF1E2CE-8B4C-4DCD-B68C-44B83D7831A2Q36175526-7643B1E9-C12E-482B-AD38-CEAC9528FF95Q36294761-9BE751E1-7A80-4172-85DD-F386131C0727Q36660907-27554E35-880A-4557-96E3-AC9D5DF4802CQ36662986-77B21BB1-1A8C-45DB-B913-9326F346F5AEQ36771826-168090F7-C39A-424F-865D-A46F5F39B3B7Q36878452-CFC7B065-E195-4E84-8524-237A5FD3D6AAQ36945848-29ED5418-D347-49A9-BAA1-CD7C67A399CCQ37178997-5E4F51B4-8482-4341-A690-3D3EF056E8BEQ37208542-640DB8E4-F2CB-42D3-977C-BFAD0E889330Q39029439-B8E373D5-4EDD-4945-AFA4-BCC6BE15020CQ39254699-2F587C98-9AC0-4BF7-8FF9-F42E5A8217FFQ39455829-E53C255C-9758-4E8E-80FB-61C1523A8CE4Q42363315-05B72A0A-8C06-4118-8498-FD29AB58A54FQ45872420-9A641655-B4D3-4BE6-AAD6-0F1DFC7949FEQ47443520-1583E98E-D53C-4177-A779-D9214080A6F6Q49650521-37F84554-0A8F-4C9C-8905-68D43C7360B7Q50863793-630949D4-9723-45CC-BAF9-DF32DE37C847Q52726708-9F91C720-7E13-47D7-8C70-6EB65254B2B9Q58793328-75E96B59-D9DF-4EC8-AEF2-371B7DF0D02E
P2860
Shelterin complex and associated factors at human telomeres
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Shelterin complex and associated factors at human telomeres
@ast
Shelterin complex and associated factors at human telomeres
@en
Shelterin complex and associated factors at human telomeres
@nl
type
label
Shelterin complex and associated factors at human telomeres
@ast
Shelterin complex and associated factors at human telomeres
@en
Shelterin complex and associated factors at human telomeres
@nl
prefLabel
Shelterin complex and associated factors at human telomeres
@ast
Shelterin complex and associated factors at human telomeres
@en
Shelterin complex and associated factors at human telomeres
@nl
P2860
P3181
P356
P1433
P1476
Shelterin complex and associated factors at human telomeres
@en
P2093
Diego Loayza
Raffaella Diotti
P2860
P304
P3181
P356
10.4161/NUCL.2.2.15135
P407
P577
2011-01-01T00:00:00Z